Fujifilm's factory in Denmark generates USD 430m revenue

Fujifilm Diosynth Biotechnologies, a Japan-based company that produces drugs for other firms, has released its first annual accounting report since it started operating in Denmark. This comes two years after the company bought a medicine factory in the country.
Lars Petersen, CEO of Fujifilm Diosynth Biotechnologies in Denmark | Photo: Fujifilm Diosynth Biotechnologies
Lars Petersen, CEO of Fujifilm Diosynth Biotechnologies in Denmark | Photo: Fujifilm Diosynth Biotechnologies
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY CATHERINE BRETT

Two years after Fujifilm Diosynth Biotechnologies (FDB) spent DKK 6bn (USD 960m) on a medicine factory in Northern Zealand, Denmark, the contract producer has released its first annual accounting report for its Danish operations.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading